| Literature DB >> 889752 |
Abstract
Intravenous glucose tolerance tests, and estimations of prothrombin time, and plasma coagulation factors VII and X, were made on 12 women receiving 200 mg norethisterone oenanthate intramuscularly as a contraceptive. These estimations were made before, and at 2 and 12 weeks after, a single injection of norehisterone oenanthate. There was no significant effect on the intravenous glucose tolerance, prothrombin time, or on plasma coagulation factors VII and X, further confirming the safety of norehisterone oenanthate when used as a short-term injectable contraceptive.Entities:
Keywords: Biology; Blood Coagulation Effects; Carbohydrate Metabolic Effects; Clinical Research; Contraception; Contraceptive Agents, Female--administraction and dosage; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--administraction and dosage; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--administraction and dosage; Contraceptive Agents--side effects; Examinations And Diagnoses; Family Planning; Glucose Metabolism Effects; Glucose Tolerance Test; Hematological Effects; Hemic System; Injectables; Laboratory Examinations And Diagnoses; Laboratory Procedures; Norethindrone Enanthate--administraction and dosage; Norethindrone Enanthate--side effects; Norethindrone--administraction and dosage; Norethindrone--side effects; Physiology; Research Methodology
Mesh：
Substances：
Year: 1977 PMID： 889752 DOI： 10.1111/j.1471-0528.1977.tb12665.x
Source DB: PubMed Journal: Br J Obstet Gynaecol ISSN： 0306-5456